Pharmaroth Labs Inc. logo

Pharmaroth Labs Inc. (ROTH)

Market Closed
11 Aug, 20:00
EXPM EXPM
$
0. 00
0
0%
$
3.51K Market Cap
- P/E Ratio
- Div Yield
20,000 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track ROTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Pharmaroth Labs Inc. (ROTH) Statistics

Valuation metrics

Market Cap 3.51K
Enterprise value 252.35K
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.02
Price/Book (mrq) -0.01
Enterprise Value/Revenue 1.39
Enterprise Value/EBITDA -2.76

Overview

Shares outstanding 149.35M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4K
Average volume (90 days) 3.42K

Price summary

52-Week low 0
52-Week high 0
Beta 0.67
50-Day moving average 0
200-Day moving average 0

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 5:1
Last split Date 1 Jun 2010

Financials

Fiscal year

Fiscal year ends 30 Jun 2010
Most recent quarter (mrq) 30 Jun 2010

Profitability

Profit margin -0.5%
Operating margin -0.5%

Operational effectiveness

Return on assets -0.3%
Return on equity 0.18%

Income Statement

Revenue (ttm) 200.15K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) 80.48K
EBITDA -
Net income to common (ttm) -557.63K
Diluted EPS (ttm) -0
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 33
Total cash per share (mrq) 0
Total debt (mrq) 250K
Total Debt/Equity (mrq) -0.45
Current ratio (mrq) 0.35%
Book value per share (mrq) -0

Cash Flow

Cash flow statement -170.46K
Levered free cash flow (LFCF) -